¡ÖÆüËܿͤÎ50¿Í¤Ë1¿Í¤¬¼Ð»ë¡×¼ãǯÁØ¡¦¹âÎðÁؤ˸²Ãø µþÅÔÂç³Ø¤é¸¦µæ¥°¥ëー¥×¤¬È¯É½

¼Ì¿¿³ÈÂç

µþÅÔÂç³Ø¤é¤Î¸¦µæ¥°¥ëー¥×¤ÏÆüËܿͤˤª¤±¤ë¼Ð»ë¤ÎȯÀ¸¾õ¶·¤ò²òÀϤ·¡¢2020ǯ»þÅÀ¤Î¼Ð»ë¤ÎÍ­ÉÂΨ¤¬2.154¡ó¤È¤¤¤¦·ë²Ì¤òȯɽ¤·¤Þ¤·¤¿¡£¤³¤ÎÆâÍƤˤĤ¤¤ÆÌø°å»Õ¤Ë»Ç¤¤¤Þ¤·¤¿¡£

´Æ½¤°å»Õ¡§
Ìø Ì÷ͺ¡Ê°å»Õ¡Ë

ÅìµþÂç³Ø°å³ØÉô´¶È¡£¤½¤Î¸å¡¢ÅìµþÂç³ØÂç³Ø±¡½¤Î»¡¢ÅìµþÂç³Ø°å³ØÉô´ã²Ê³Ø¶µ¼¼¹Ö»Õ¡¢¥Ç¥åー¥¯¡¦¥·¥ó¥¬¥Ýー¥ë¹ñΩÂç³Ø°å³ØÉô½Ú¶µ¼ø¡¢°°Àî°å²ÊÂç³Ø´ã²Ê³Ø¶µ¼¼¶µ¼ø¤ò̳¤á¤ë¡£¸½ºß¤Ï²£ÉÍ»ÔΩÂç³Ø»ë³ÐºÆÀ¸³°²Ê³Ø¶µ¼¼µÒ°÷¶µ¼ø¡¢ÅìµþÅÔ³ë¾þ¶è¤Ë°ÌÃÖ¤¹¤ë¡Ö¤ª²ÖÃã²°´ã²Ê¡×±¡Ä¹¡¢¡ÖDeepEyeVision³ô¼°²ñ¼Ò¡×¼èÄùÌò¡£°å³ØÇî»Î¡¢ÆüËÜ´ã²Ê³Ø²ñÀìÌç°å¡£

ȯɽ¤·¤¿¸¦µæÆâÍƤȤϡ©

º£²ó¡¢µþÅÔÂç³Ø¤é¤Ë¤è¤ë¸¦µæ¥°¥ëー¥×¤¬È¯É½¤·¤¿¸¦µæÆâÍƤˤĤ¤¤Æ¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£

ÌøÀèÀ¸

º£²ó¾Ò²ð¤¹¤ë¸¦µæ¤ÏµþÅÔÂç³Ø¤é¤Î¸¦µæ¥°¥ëー¥×¤Ë¤è¤ë¤â¤Î¤Ç¡¢À®²Ì¤Ï³Ø½Ñ»¨»ï¡ÖAmerican Journal of Ophthalmology¡×¤Ë·ÇºÜ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¸¦µæ¥°¥ëー¥×¤Ï¡¢¸üÀ¸Ï«Æ¯¾Ê¤Îƿ̾°åÎÅÊݸ±Åù´ØÏ¢¾ðÊó¥Çー¥¿¥Ùー¥¹¤ò²òÀϤ·¤Þ¤·¤¿¡£¤½¤Î·ë²Ì¡¢2020ǯ10·î1Æü»þÅÀ¤Ç¡¢ÆüËܤο͸ý1²¯2570Ëü8000¿ÍÃæ270Ëü9207¿Í¤¬¼Ð»ë¤È¿ÇÃǤµ¤ì¡¢¼Ð»ë¤ÎÍ­ÉÂΨ¤Ï2.154¡ó¤È»»½Ð¤·¤¿¤³¤È¤òȯɽ¤·¤Þ¤·¤¿¡£¼Ð»ë¤ÎÍ­ÉÂΨ¤Ï³ØÎð´ü¤Ç¹â¤¯¤Ê¤ë·¹¸þ¤¬¤ß¤é¤ì¡¢5~9ºÐ¤Ç6.019¡ó¡¢10~14ºÐ¤Ç7.652¡ó¡¢15~19ºÐ¤Ç5.664¡ó¤Ç¤·¤¿¡£¤Þ¤¿¡¢¹âÎð¼Ô¤âÍ­ÉÂΨ¤Ï¹â¤¯¤Ê¤ê¡¢75~79ºÐ¤Ç2.611¡ó¡¢80~84ºÐ¤Ç2.762¡ó¡¢85~89ºÐ¤Ç2.495¡ó¤È¤¤¤¦·ë²Ì¤Ë¤Ê¤ê¤Þ¤·¤¿¡£¼ãǯÁؤǤϽ÷À­¡¢¹âÎðÁؤǤÏÃËÀ­¤ÎÍ­ÉÂΨ¤¬¹â¤¤·¹¸þ¤¬¤ß¤é¤ì¤Þ¤·¤¿¡£

°Ê¾å¤Î·ë²Ì¤«¤é¡¢¸¦µæ¥°¥ëー¥×¤Ï¡Ö¼Ð»ë¤ÎÍ­ÉÂΨ¡¦È¯À¸Î¨¤ÏÆóÊöÀ­¤ÎǯÎðʬÉÛ¤ò¼¨¤·¡¢³ØÎð´ü¤«¤éÃæǯ´ü¤Ë¤«¤±¤Æ¤ÎÍ­ÉÂΨ¤Ï¼Ð»ë¼ê½Ñ¤Ë¤è¤êÄã²¼¤·¤Æ¤¤¤ë²ÄǽÀ­¤¬¼¨º¶¤µ¤ì¤¿¡×¤È·ëÏÀ¤Å¤±¤Æ¤¤¤Þ¤¹¡£¤Þ¤¿¡¢¼ãǯÁؤǤϽ÷À­¡¢¹âÎðÁؤǤÏÃËÀ­¤ÎÍ­ÉÂΨ¤¬¹â¤¤·¹¸þ¤¬¤ß¤é¤ì¤¿¤³¤È¤Ë¤Ä¤¤¤Æ¤Ï¡Ö¼ãǯÃËÀ­´µ¼Ô¤ÈÈæ¤Ù¤Æ¡¢¼ãǯ½÷À­´µ¼Ô¤Ï¿´Íý¼Ò²ñŪ¤ÊÉÔÍø±×¤òÈï¤ë¤³¤È¤¬Â¿¤¤¤È¤¤¤¦Íýͳ¤«¤é¡¢´ã²Ê¤Î¼õ¿ÇΨ¤ª¤è¤Ó¼Ð»ë»Ü½Ñ¤Î»Ü¹ÔΨ¤¬¹â¤¯¤Ê¤Ã¤Æ¤¤¤ë²ÄǽÀ­¤¬¤¢¤ë¡×¤È½Ò¤Ù¤Æ¤¤¤Þ¤¹¡£

¼Ð»ë¤È¤Ï¡©

µþÅÔÂç³Ø¤é¤Ë¤è¤ë¸¦µæ¥°¥ëー¥×¤¬¸¦µæÂоݤˤ·¤¿¼Ð»ë¤Ë¤Ä¤¤¤Æ¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£

ÌøÀèÀ¸

¼Ð»ë¤È¤Ïº¸±¦¤Î´ã¤¬°ã¤¦Êý¸þ¤ò¤ß¤Æ¤¤¤ë¾õÂ֤ǡ¢¡Ö³°¼Ð»ë¡×¡ÖÆâ¼Ð»ë¡×¡Ö¾å²¼¼Ð»ë¡×¤Ê¤É¤ËʬÎव¤ì¤Þ¤¹¡£³°¼Ð»ë¤ÏÊÒÊý¤Î´ã¤¬ÌÜɸ¤ò¸«¤Æ¤¤¤Æ¡¢¤½¤ÎÈ¿ÂФδ㤬ÀµÌ̤è¤ê³°¤Ë¸þ¤¤¤Æ¤¤¤ë¾õÂ֤ǡ¢Æâ¼Ð»ë¤ÏÆ⦤ò¸þ¤¤¤Æ¤¤¤ë¾õÂ֤Ǥ¹¡£

¤µ¤é¤Ë¡¢¼Ð»ë¤ÏÌܤòÆ°¤«¤¹¶ÚÆù¤Ë¸¶°ø¤¬¤¢¤ë¡ÖËãáãÀ­¼Ð»ë¡×¡¢Ëãá㤬¤Ê¤¤¡Ö¶¦Æ±À­¼Ð»ë¡×¤Ëʬ¤±¤é¤ì¤Þ¤¹¡£¾®»ù¤Î¼Ð»ë¤Ï¤Û¤È¤ó¤É¤¬¶¦Æ±À­¼Ð»ë¤Ç¡¢¤½¤Î¸¶°ø¤ÏÉÔÌÀ¤Ç¤¹¡£¾ÉÎã¤Ë¤è¤Ã¤Æ¤Ï¡¢ÌܤòÆ°¤«¤¹¶ÚÆù¤äÌ¿Îá¤ò½Ð¤¹Ç¾¿À·Ð¡¢¼Ð»ë°Ê³°¤ÎÌܤÎɵ¤¤Î̵ͭ¡¢Á´¿ÈŪ¤Êɵ¤¤¬¤Ê¤¤¤«¤Î¸¡ºº¤¬É¬Íפˤʤ뤳¤È¤â¤¢¤ê¤Þ¤¹¡£¼Ð»ë¤Ï¡Ö»ëÎϤ¬È¯Ã£¤·¤Ë¤¯¤¤¡×¡ÖΩÂλë¤Ê¤É¤¬È¯Ã£¤·¤Ê¤¤¡¢¤Þ¤¿¤Ï»È¤¨¤Ê¤¤¡×¡Ö¤â¤Î¤¬2¤Ä¤Ë¸«¤¨¤ë¡×¤Ê¤É¤Î±Æ¶Á¤¬¹Í¤¨¤é¤ì¤Þ¤¹¡£´ã¶À¤ä¼Ð»ë¼ê½Ñ¡¢·±Îý¤È¤¤¤Ã¤¿¼£ÎÅË¡¤¬¤¢¤ê¤Þ¤¹¡£

º£²ó¤Î¸¦µæÆâÍƤؤμõ¤±»ß¤á¤Ï¡©

µþÅÔÂç³Ø¤é¤Ë¤è¤ë¸¦µæ¥°¥ëー¥×¤¬È¯É½¤·¤¿¸¦µæÆâÍƤؤμõ¤±»ß¤á¤ò¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£

ÌøÀèÀ¸

º£²ó¤Î¸¦µæ¤Ï¡¢É±¡¤ò¼õ¿Ç¤·¤Æ¼Ð»ë¤È¿ÇÃǤµ¤ì¤¿´µ¼Ô¿ô¤¬¤É¤ì¤¯¤é¤¤¤¤¤¿¤Î¤«¤òÄ´ºº¤·¤¿¤â¤Î¤Ç¤¹¡£¼ÂºÝ¤Ë¤Ï¡¢¼Ð»ë¤¬¤¢¤Ã¤Æ¤âɱ¡¤ò¼õ¿Ç¤·¤Æ¤¤¤Ê¤¤¿Í¤¬¤¤¤ë¤Î¤Ç¡¢¤³¤¦¤·¤¿¿Í¤ò´Þ¤á¤ë¤Èº£²ó¤ÎÊó¹ð¤è¤ê¤âÍ­ÉÂΨ¤Ï¹â¤¤¤È¿ä»¡¤µ¤ì¤Þ¤¹¡£¤½¤Î°ìÊý¤Ç¡¢¼Ð»ë¤ÎÍ­ÉÂΨ¤Ï¤³¤ì¤Þ¤Ç¤Î³¤³°¤ÎÊó¹ð¤È¤Û¤ÜƱÄøÅ٤Ǥ¢¤ê¡¢¤«¤Ê¤êÀºÅ٤ι⤤Êó¹ð¤Ç¤¢¤ë¤È¸À¤¨¤Þ¤¹¡£¤µ¤é¤Ë¡¢º£²ó¤ÎÄ´ºº¤Ç½é¤á¤ÆÆüËܤǤâ¼ãǯÀ­¤Î¼Ð»ë¤È²ÃÎð¤Ëȼ¤¦¼Ð»ë¤¬¤¢¤ê¡¢Í­ÉÂΨ¤¬ÆóÊöÀ­¤Ç¤¢¤ë¤³¤È¤¬¤Ï¤Ã¤­¤ê¤È¼¨¤µ¤ì¤Þ¤·¤¿¡£

¼Ð»ë¤Î¸¶°ø¤ÏÍÍ¡¹¤Ê¤â¤Î¤¬¤¢¤ê¤Þ¤¹¡£ºÇ¶á¤Ç¤Ï¡¢¥¹¥Þー¥È¥Õ¥©¥ó¤Î¸«²á¤®¤¬¸¶°ø¤È»×¤ï¤ì¤ë¡Ö¥¹¥Þ¥ÛÆâ¼Ð»ë¡×¤â¤ß¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤Æ¤­¤Þ¤·¤¿¡£¤Þ¤¿¡¢²ÃÎð¤Ëȼ¤¦¼Ð»ë¡Ö²ÃÎðÀ­¼Ð»ë¡ÊSagging eye syndrome¡Ë¡×¤Ï¡¢ºÇ¶á¤Ë¤Ê¤Ã¤Æ¸¶°ø¤¬È½ÌÀ¤·¤Ä¤Ä¤¢¤ê¤Þ¤¹¡£µ¤¤Ë¤Ê¤ëÌܤξɾõ¤¬¤¢¤ì¤Ð¡¢¤Ç¤­¤ë¤À¤±Á᤯´ã²Ê¤ËÁêÃ̤ò¤·¤Æ¤ß¤Æ¤Ï¤¤¤«¤¬¤Ç¤·¤ç¤¦¤«¡£

¤Þ¤È¤á

µþÅÔÂç³Ø¤é¤Î¸¦µæ¥°¥ëー¥×¤¬ÆüËܿͤˤª¤±¤ë¼Ð»ë¤ÎȯÀ¸¾õ¶·¤ò²òÀϤ·¡¢2020ǯ»þÅÀ¤Î¼Ð»ë¤ÎÍ­ÉÂΨ¤¬2.154¡ó¤È¤¤¤¦·ë²Ì¤òȯɽ¤·¤Þ¤·¤¿¡£¡ÖÆüËܿͤÎ50¿Í¤Ë1¿Í¤¬¼Ð»ë¡×¤È¤¤¤¦·ë²Ì¤ÏÃíÌܤò½¸¤á¤½¤¦¤Ç¤¹¡£

¶á¤¯¤Î´ã²Ê¤òõ¤¹